BONE CARE INTERNATIONAL INC 4
4 · BONE CARE INTERNATIONAL INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
FREITAG JEFFREY J
VP-Research & Development
Transactions
- Disposition to Issuer
BCII Stock Option Plan
2005-07-01$22.09/sh−142,000$3,136,780→ 0 totalExercise: $10.91Exp: 2013-06-09→ BCII Common Stock (142,000 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$33.00/sh−147,000$4,851,000→ 0 total - Disposition to Issuer
BCII Restricted Stock Units
2005-07-01$33.00/sh−6,667$220,011→ 0 total - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$11.88/sh−5,000$59,400→ 0 totalExercise: $21.12Exp: 2014-06-22→ BCII Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per BCII Restricted Stock Unit.
- [F3]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.